Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.bcp.2017.04.004

http://scihub22266oqcxt.onion/10.1016/j.bcp.2017.04.004
suck pdf from google scholar
C5841551!5841551 !28390938
unlimited free pdf from europmc28390938
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28390938 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid28390938
      Biochem+Pharmacol 2017 ; 139 (?): 40-55
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Natural product-based amyloid inhibitors #MMPMID28390938
  • Velander P ; Wu L ; Henderson F ; Zhang S ; Bevan DR ; Xu B
  • Biochem Pharmacol 2017[Sep]; 139 (?): 40-55 PMID28390938 show ga
  • Many chronic human diseases, including multiple neurodegenerative diseases, are associated with deleterious protein aggregates, also called protein amyloids. One common therapeutic strategy is to develop protein aggregation inhibitors that can slow down, prevent, or remodel toxic amyloids. Natural products are a major class of amyloid inhibitors, and several dozens of natural product-based amyloid inhibitors have been identified and characterized in recent years. These plant- or microorganism-extracted compounds have shown significant therapeutic potential from in vitro studies as well as in vivo animal tests. Despite the technical challenges of intrinsic disordered or partially unfolded amyloid proteins that are less amenable to characterizations by structural biology, a significant amount of research has been performed, yielding biochemical and pharmacological insights into how inhibitors function. This review aims to summarize recent progress in natural product-based amyloid inhibitors and to analyze their mechanisms of inhibition in vitro. Major classes of natural product inhibitors and how they were identified are described. Our analyses comprehensively address the molecular interactions between the inhibitors and relevant amyloidogenic proteins. These interactions are delineated at molecular and atomic levels, which include covalent, non-covalent, and metal-mediated mechanisms. In vivo animal studies and clinical trials have been summarized as an extension. To enhance natural product bioavailability in vivo, emerging work using nanocarriers for delivery has also been described. Finally, issues and challenges as well as future development of such inhibitors are envisioned.
  • |*Dietary Supplements [MESH]
  • |*Drug Design [MESH]
  • |*Drug Discovery [MESH]
  • |Amyloidogenic Proteins/*antagonists & inhibitors/metabolism [MESH]
  • |Amyloidosis/diet therapy/drug therapy/metabolism/*prevention & control [MESH]
  • |Animals [MESH]
  • |Anti-Inflammatory Agents, Non-Steroidal/chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Antioxidants/chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Biological Products/*chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Chelating Agents/chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Diet, Healthy [MESH]
  • |Drugs, Investigational/chemistry/pharmacology/*therapeutic use [MESH]
  • |Flavonoids/chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Humans [MESH]
  • |Nootropic Agents/chemistry/metabolism/pharmacology/therapeutic use [MESH]
  • |Polyphenols/chemistry/metabolism/pharmacology/therapeutic use [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box